maritide glp-1 What to know about MariTide, Amgen's experimental drug Future obesity treatment -phase 1

Missing one day from your standard seven-day cycle creates a six-day interval, which may affect satiety signaling, appetite suppression effectiveness, and gastrointestinal side effects

Archived from the original on 28 September 2024

Conflicts of Interest ID has received fees from Astra Zeneca, Novonordisk, Abbott, Boeringham Ingleheimer, Elli Lilly and Sanofi for educational lectures, and participated in advisory boards of Elli Lilly, Novonordisk, Boeringham Ingleheimer, Sanofi and Novartis that are outside the scope of this work

The Biology of Natural GLP-1 Activation GLP-1 (glucagon-like peptide-1) is secreted by intestinal L-cells in response to nutrient sensing, particularly glucose, amino acids, and certain fats

DATA AVAILABILITY The datasets and reagents generated during the current study are available from the corresponding author upon reasonable request

The development of hypothalamic obesity in craniopharyngioma patients: a risk factor analysis in a well-defined cohort